EWA
DGX icon

Exencial Wealth Advisors’s Quest Diagnostics DGX Stock Holding History

Exencial Wealth Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.6M Sell
59,260
-2,860
-5% -$556K 0.36% 75
2025
Q4 		$10.8M Sell
62,120
-1,292
-2% -$235K 0.34% 86
2025
Q3 		$12.1M Sell
63,412
-581
-0.9% -$103K 0.39% 77
2025
Q2 		$11.5M Sell
63,993
-3,186
-5% -$553K 0.4% 79
2025
Q1 		$11.4M Sell
67,179
-121
-0.2% -$19.9K 0.42% 76
2024
Q4 		$10.2M Sell
67,300
-1,967
-3% -$306K 0.37% 77
2024
Q3 		$10.8M Sell
69,267
-1,039
-1% -$155K 0.39% 79
2024
Q2 		$9.62M Sell
70,306
-4,553
-6% -$624K 0.36% 83
2024
Q1 		$9.96M Sell
74,859
-606
-0.8% -$78.6K 0.37% 81
2023
Q4 		$10.4M Buy
75,465
+2,814
+4% +$370K 0.42% 73
2023
Q3 		$8.85M Buy
72,651
+55,375
+321% +$7.38M 0.43% 74
2023
Q2 		$2.43M Buy
17,276
+256
+2% +$35.3K 0.11% 170
2023
Q1 		$2.41M Buy
17,020
+855
+5% +$122K 0.12% 160
2022
Q4 		$2.53M Buy
16,165
+2,031
+14% +$292K 0.14% 160
2022
Q3 		$1.73M Buy
14,134
+404
+3% +$53.2K 0.1% 172
2022
Q2 		$1.83M Sell
13,730
-35
-0.3% -$4.77K 0.1% 176
2022
Q1 		$1.88M Buy
13,765
+558
+4% +$77.8K 0.09% 187
2021
Q4 		$2.29M Buy
13,207
+325
+3% +$49.5K 0.11% 181
2021
Q3 		$1.87M Buy
12,882
+2,738
+27% +$401K 0.08% 154
2021
Q2 		$1.34M Sell
10,144
-2,042
-17% -$267K 0.07% 211
2021
Q1 		$1.56M Buy
12,186
+2,295
+23% +$283K 0.09% 186
2020
Q4 		$1.18M Sell
9,891
-12,152
-55% -$1.48M 0.08% 184
2020
Q3 		$2.52M Buy
22,043
+12,248
+125% +$1.45M 0.13% 158
2020
Q2 		$1.12M Buy
+9,795
New +$1.04M 0.1% 169

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Exencial Wealth Advisors's DGX Position: Q1 2026 in Review

Exencial Wealth Advisors reduced its Quest Diagnostics (DGX) stake by 4.6% in Q1 2026, selling an estimated $556K and leaving 59,260 shares worth $11.6M. The position accounts for 0.36% of the portfolio, ranked #75.

Exencial Wealth Advisors first reported a position in DGX in Q2 2020 and has held it in 24 quarters since. The position peaked at $12.1M in Q3 2025. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Exencial Wealth Advisors held 59,260 shares of Quest Diagnostics worth $11.6M as of Q1 2026.
  • Exencial Wealth Advisors sold 2,860 Quest Diagnostics shares in Q1 2026, an estimated $556K.
  • Quest Diagnostics made up 0.36% of Exencial Wealth Advisors's portfolio in Q1 2026, its #75 holding.
  • Exencial Wealth Advisors first reported a position in Quest Diagnostics in Q2 2020 and has held it in 24 quarters since.
  • Exencial Wealth Advisors's Quest Diagnostics position peaked at $12.1M in Q3 2025.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Exencial Wealth Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.